Marksans Pharma Ltd Quarterly Results

Gross Sales

708.46

681.85

641.92

590.62

560.01

Excise Duty

0

0

0

0

0

Net Sales

708.46

681.85

641.92

590.62

560.01

Other Operating Income

0

0

0

0

0

Other Income

16.52

27.85

11.06

14.95

16.53

Total Income

724.98

709.7

652.98

605.57

576.54

Total Expenditure

582.7

543.08

506.24

462.18

450.37

PBIDT

142.27

166.61

146.74

143.39

126.17

Interest

3.44

2.67

2.63

2.92

4.84

PBDT

138.84

163.95

144.11

140.46

121.33

Depreciation

22.74

20.69

19.51

20.44

21.06

Minority Interest Before NP

0

0

0

0

0

Tax

24.28

38.01

36.29

30.01

30.74

Deferred Tax

1.09

0.18

-9.45

0.94

-8.11

Reported Profit After Tax

90.73

105.07

97.76

89.07

77.64

Minority Interest After NP

0.18

0.5

1.04

0.32

-0.65

Net Profit after Minority Interest

90.55

104.56

96.72

88.75

78.29

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

90.55

104.56

96.72

88.75

78.29

EPS (Unit Curr.)

2

2.31

2.13

1.96

1.73

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

45.32

45.32

45.32

45.32

45.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.08

24.43

22.85

24.27

22.52

PBDTM(%)

19.59

24.04

22.44

23.78

21.66

PATM(%)

12.8

15.4

15.22

15.08

13.86